Hepatotoxicity of antipsychotics: an exploratory pharmacoepidemiologic and pharmacodynamic study integrating FAERS data and in vitro receptor-binding affinities
Our findings suggest that the serotonin and probably the cholinergic system may play a role in the development of DILI related to antipsychotic medications. The identification of antipsychotics with a higher association with DILI, such as chlorpromazine, underscores the need for careful monitoring in clinical practice. However, our findings need further longitudinal studies to confirm causality. A better understanding of the associations may inform clinical decision-making, particularly in patients with an increased susceptibility to liver damage.
Authors
- Bernhard J. Connemann (ORCID: https://orcid.org/0000-0002-0338-0729)
- Susanne Häfner (ORCID: https://orcid.org/0000-0003-0663-8382)
- René Zeiss (ORCID: https://orcid.org/0000-0002-2471-8004)
- Carlos Schönfeldt‐Lecuona (ORCID: https://orcid.org/0000-0002-7147-6562)
- Maximilian Gahr (ORCID: https://orcid.org/0000-0002-1383-4691)
Institutions
- Universität Ulm (DE)
- BDH-Klinik Hessisch Oldendorf (DE)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2024-10-14
- DOI
- https://doi.org/10.3389/fpsyt.2024.1479625
- Citations
- 4
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 1.87